human circrna microarray version 2.0 Search Results


ku812  (ATCC)
95
ATCC ku812
AGAP2 mRNA and protein levels discrepancies (A) AGAP2 mRNA basal levels were measured in prostate cancer (PC) cell lines (DU145, PC3, LNCaP) and chronic myeloid leukemia (CML) cell lines <t>(KU812,</t> TCC-S, KCL-22) by RT-qPCR. The values presented were normalized against the levels of the housekeeping gene HPRT and shown relative to the prostate cancer cell line DU145. Statistical analyses were carried out by one-way ANOVA[F (5, 12) = 21.23, p < 0.0001)] with post-hoc Sidak’s multiple comparison tests. (B) Representative image of AGAP2 protein levels detected by immunoblotting in CML and PC cell lines. β-Actin was used a loading control. Densitometry values for the relative protein expression are represented below the blots. Differences were analyzed using Kruskal-Wallis [H (5) = 14.71, p = 0.012] followed by uncorrected Dunn’s test. (C) Strong negative correlation between AGAP2 mRNA (x axis) and protein levels (y axis) in PC and CML cell lines (Pearson’s R = −0.89, p = 0.016). The data presented is relative to DU145 (PC cell line). (D and E) AGAP2 relative mRNA levels (D) and protein (E) in different cancer cell lines, assessed as described in (A) and (B). Statistical analyses for mRNA levels in (D) were carried out by one-way ANOVA[F (9, 20) = 41.30, p < 0.001)] with post-hoc Sidak’s multiple comparison tests. (F and G) Western blot analysis for the accumulation of ubiquitinated proteins (as positive control for the proteasomal inhibitors) and AGAP2 levels in CML cell lines treated with proteasomal inhibitors: MG132 [KU812 (5 μM), TCC-S (5 μM), KCL-22 (50 μM) for 4 h] and Bortezomib [KU812 (200 nM), TCC-S (10 nM), KCL-22 (100 nM) for 6 h]. β-Actin levels were used as a loading control. All data shown in the graphs in this figure are the mean ± SD from three independent experiments (performed in triplicate in the case of qPCRs); (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001).
Ku812, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ku812/product/ATCC
Average 95 stars, based on 1 article reviews
ku812 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Arraystar inc human circrna microarray 8×15k
<t> CircRNA_103827 </t> and circRNA_104816 expressions in granulosa cells according to patients’ clinical characteristics.
Human Circrna Microarray 8×15k, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human circrna microarray 8×15k/product/Arraystar inc
Average 90 stars, based on 1 article reviews
human circrna microarray 8×15k - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc circrna expression microarray slide
circRNAs expression profiles detected by <t>microarray</t> in the AAA group and control group. a The box plot shows the nearly identical distributions of normalized intensity values from the aortic samples of the AAA and control group. b The scatter plot is built to assess the expression variation of circRNAs between the two groups. The X and Y axes indicate the normalized intensity values of each circRNAs from the AAA and control group. The dots above the upper green line and below the lower green line represent the dysregulated circRNAs with a fold change (FC) > 2.0 between the two groups. c The volcano plot presents differentially expressed circRNAs in AAA. The vertical lines correspond to 2-fold upregulation and downregulation, the horizontal line indicates P value of 0.05. The red dots represent the differentially expressed circRNAs (FC > 2.0 and P value < 0.05). d Hierarchical clustering analysis reveals a distinguishable expression profile of circRNAs between the AAA and control group. Each column indicates an aortic sample, each row represents a <t>circRNA.</t> The red and green color indicate high and low expression level, respectively. e Chromosomal distribution of the differentially expressed circRNAs between the two groups
Circrna Expression Microarray Slide, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/circrna expression microarray slide/product/Arraystar inc
Average 90 stars, based on 1 article reviews
circrna expression microarray slide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies circrna microarray (version 2.0
Comparison of <t>circRNA</t> expression profiles between HPA-v and adipocytes. (A) Box plots revealed the distribution of circRNAs in the six samples after normalization. (B) Volcano plots revealed the differentially expressed circRNAs. Green and red dots represent significantly down- and upregulated circRNAs in adipocytes compared with HPA-v, respectively (fold change ≥5.0, P<0.01). (C) Hierarchical clustering was performed to reveal the differentially expressed circRNAs between HPA-v and adipocytes. (D) Expression patterns of select differentially expressed circRNAs in HPA-v and adipocytes were determined by qPCR. (E) The heatmap revealed the selected differentially expressed circRNAs in HPA-v and adipocytes. *P<0.05. circRNA, circular RNA; HPA-v, human preadipocytes from visceral fat tissue; AD, adipocytes; n.d., not detected.
Circrna Microarray (Version 2.0, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/circrna microarray (version 2.0/product/Agilent technologies
Average 90 stars, based on 1 article reviews
circrna microarray (version 2.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc agilent-069978 human circrna microarray v1
Comparison of <t>circRNA</t> expression profiles between HPA-v and adipocytes. (A) Box plots revealed the distribution of circRNAs in the six samples after normalization. (B) Volcano plots revealed the differentially expressed circRNAs. Green and red dots represent significantly down- and upregulated circRNAs in adipocytes compared with HPA-v, respectively (fold change ≥5.0, P<0.01). (C) Hierarchical clustering was performed to reveal the differentially expressed circRNAs between HPA-v and adipocytes. (D) Expression patterns of select differentially expressed circRNAs in HPA-v and adipocytes were determined by qPCR. (E) The heatmap revealed the selected differentially expressed circRNAs in HPA-v and adipocytes. *P<0.05. circRNA, circular RNA; HPA-v, human preadipocytes from visceral fat tissue; AD, adipocytes; n.d., not detected.
Agilent 069978 Human Circrna Microarray V1, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/agilent-069978 human circrna microarray v1/product/Arraystar inc
Average 90 stars, based on 1 article reviews
agilent-069978 human circrna microarray v1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies arraystar human circrna microarray v1
IDD datasets included for analysis
Arraystar Human Circrna Microarray V1, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/arraystar human circrna microarray v1/product/Agilent technologies
Average 90 stars, based on 1 article reviews
arraystar human circrna microarray v1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Agilent technologies circrna microarray analysis
IDD datasets included for analysis
Circrna Microarray Analysis, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/circrna microarray analysis/product/Agilent technologies
Average 90 stars, based on 1 article reviews
circrna microarray analysis - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc gpl21825 074301 arraystar human circrna microarray v2
IDD datasets included for analysis
Gpl21825 074301 Arraystar Human Circrna Microarray V2, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gpl21825 074301 arraystar human circrna microarray v2/product/Arraystar inc
Average 90 stars, based on 1 article reviews
gpl21825 074301 arraystar human circrna microarray v2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc human circrnas microarray
Schematic illustration of the effect of circular RNAs <t>(circRNAs)</t> on intracranial aneurysm (IA) rupture. Current evidence strongly suggests a central role for endothelial dysfunction in the initiation and progression of IA. Post-subarachnoid hemorrhage (SAH), several early pathophysiological events can be commonly observed in blood-brain barrier (BBB) components, such as the endothelium (endothelial dysfunction). In results, post- SAH injuries can disrupt the integrity and function of the BBB . Both negative (red cross) and positive (green cross) regulation of circRNAs have been observed in this pathological cascade. The role of circRNAs is based on components: 1) strong role in endothelial cells (ECs) homeostasis; 2) regulation of barrier function and vascular tone; 3) associated with SAH and its complications; 4) correlates with clinical outcomes (Glasgow Coma Scale, the volume of SAH, modified Fisher scale, Hunt-Hess levels, and surgical type; 5) regulators of transcription/translation, sequesters of microRNA (miRNA)/RNA-binding proteins (RBPs), and biomarkers of IA.
Human Circrnas Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human circrnas microarray/product/Arraystar inc
Average 90 stars, based on 1 article reviews
human circrnas microarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc human circular rna microarray v2.0 chips
Schematic illustration of the effect of circular RNAs <t>(circRNAs)</t> on intracranial aneurysm (IA) rupture. Current evidence strongly suggests a central role for endothelial dysfunction in the initiation and progression of IA. Post-subarachnoid hemorrhage (SAH), several early pathophysiological events can be commonly observed in blood-brain barrier (BBB) components, such as the endothelium (endothelial dysfunction). In results, post- SAH injuries can disrupt the integrity and function of the BBB . Both negative (red cross) and positive (green cross) regulation of circRNAs have been observed in this pathological cascade. The role of circRNAs is based on components: 1) strong role in endothelial cells (ECs) homeostasis; 2) regulation of barrier function and vascular tone; 3) associated with SAH and its complications; 4) correlates with clinical outcomes (Glasgow Coma Scale, the volume of SAH, modified Fisher scale, Hunt-Hess levels, and surgical type; 5) regulators of transcription/translation, sequesters of microRNA (miRNA)/RNA-binding proteins (RBPs), and biomarkers of IA.
Human Circular Rna Microarray V2.0 Chips, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human circular rna microarray v2.0 chips/product/Arraystar inc
Average 90 stars, based on 1 article reviews
human circular rna microarray v2.0 chips - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc human circular array v2
Schematic illustration of the effect of circular RNAs <t>(circRNAs)</t> on intracranial aneurysm (IA) rupture. Current evidence strongly suggests a central role for endothelial dysfunction in the initiation and progression of IA. Post-subarachnoid hemorrhage (SAH), several early pathophysiological events can be commonly observed in blood-brain barrier (BBB) components, such as the endothelium (endothelial dysfunction). In results, post- SAH injuries can disrupt the integrity and function of the BBB . Both negative (red cross) and positive (green cross) regulation of circRNAs have been observed in this pathological cascade. The role of circRNAs is based on components: 1) strong role in endothelial cells (ECs) homeostasis; 2) regulation of barrier function and vascular tone; 3) associated with SAH and its complications; 4) correlates with clinical outcomes (Glasgow Coma Scale, the volume of SAH, modified Fisher scale, Hunt-Hess levels, and surgical type; 5) regulators of transcription/translation, sequesters of microRNA (miRNA)/RNA-binding proteins (RBPs), and biomarkers of IA.
Human Circular Array V2, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human circular array v2/product/Arraystar inc
Average 90 stars, based on 1 article reviews
human circular array v2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc microarray
Schematic illustration of the effect of circular RNAs <t>(circRNAs)</t> on intracranial aneurysm (IA) rupture. Current evidence strongly suggests a central role for endothelial dysfunction in the initiation and progression of IA. Post-subarachnoid hemorrhage (SAH), several early pathophysiological events can be commonly observed in blood-brain barrier (BBB) components, such as the endothelium (endothelial dysfunction). In results, post- SAH injuries can disrupt the integrity and function of the BBB . Both negative (red cross) and positive (green cross) regulation of circRNAs have been observed in this pathological cascade. The role of circRNAs is based on components: 1) strong role in endothelial cells (ECs) homeostasis; 2) regulation of barrier function and vascular tone; 3) associated with SAH and its complications; 4) correlates with clinical outcomes (Glasgow Coma Scale, the volume of SAH, modified Fisher scale, Hunt-Hess levels, and surgical type; 5) regulators of transcription/translation, sequesters of microRNA (miRNA)/RNA-binding proteins (RBPs), and biomarkers of IA.
Microarray, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray/product/Arraystar inc
Average 90 stars, based on 1 article reviews
microarray - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


AGAP2 mRNA and protein levels discrepancies (A) AGAP2 mRNA basal levels were measured in prostate cancer (PC) cell lines (DU145, PC3, LNCaP) and chronic myeloid leukemia (CML) cell lines (KU812, TCC-S, KCL-22) by RT-qPCR. The values presented were normalized against the levels of the housekeeping gene HPRT and shown relative to the prostate cancer cell line DU145. Statistical analyses were carried out by one-way ANOVA[F (5, 12) = 21.23, p < 0.0001)] with post-hoc Sidak’s multiple comparison tests. (B) Representative image of AGAP2 protein levels detected by immunoblotting in CML and PC cell lines. β-Actin was used a loading control. Densitometry values for the relative protein expression are represented below the blots. Differences were analyzed using Kruskal-Wallis [H (5) = 14.71, p = 0.012] followed by uncorrected Dunn’s test. (C) Strong negative correlation between AGAP2 mRNA (x axis) and protein levels (y axis) in PC and CML cell lines (Pearson’s R = −0.89, p = 0.016). The data presented is relative to DU145 (PC cell line). (D and E) AGAP2 relative mRNA levels (D) and protein (E) in different cancer cell lines, assessed as described in (A) and (B). Statistical analyses for mRNA levels in (D) were carried out by one-way ANOVA[F (9, 20) = 41.30, p < 0.001)] with post-hoc Sidak’s multiple comparison tests. (F and G) Western blot analysis for the accumulation of ubiquitinated proteins (as positive control for the proteasomal inhibitors) and AGAP2 levels in CML cell lines treated with proteasomal inhibitors: MG132 [KU812 (5 μM), TCC-S (5 μM), KCL-22 (50 μM) for 4 h] and Bortezomib [KU812 (200 nM), TCC-S (10 nM), KCL-22 (100 nM) for 6 h]. β-Actin levels were used as a loading control. All data shown in the graphs in this figure are the mean ± SD from three independent experiments (performed in triplicate in the case of qPCRs); (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001).

Journal: iScience

Article Title: Implications of differential transcription start site selection on chronic myeloid leukemia and prostate cancer cell protein expression

doi: 10.1016/j.isci.2022.105519

Figure Lengend Snippet: AGAP2 mRNA and protein levels discrepancies (A) AGAP2 mRNA basal levels were measured in prostate cancer (PC) cell lines (DU145, PC3, LNCaP) and chronic myeloid leukemia (CML) cell lines (KU812, TCC-S, KCL-22) by RT-qPCR. The values presented were normalized against the levels of the housekeeping gene HPRT and shown relative to the prostate cancer cell line DU145. Statistical analyses were carried out by one-way ANOVA[F (5, 12) = 21.23, p < 0.0001)] with post-hoc Sidak’s multiple comparison tests. (B) Representative image of AGAP2 protein levels detected by immunoblotting in CML and PC cell lines. β-Actin was used a loading control. Densitometry values for the relative protein expression are represented below the blots. Differences were analyzed using Kruskal-Wallis [H (5) = 14.71, p = 0.012] followed by uncorrected Dunn’s test. (C) Strong negative correlation between AGAP2 mRNA (x axis) and protein levels (y axis) in PC and CML cell lines (Pearson’s R = −0.89, p = 0.016). The data presented is relative to DU145 (PC cell line). (D and E) AGAP2 relative mRNA levels (D) and protein (E) in different cancer cell lines, assessed as described in (A) and (B). Statistical analyses for mRNA levels in (D) were carried out by one-way ANOVA[F (9, 20) = 41.30, p < 0.001)] with post-hoc Sidak’s multiple comparison tests. (F and G) Western blot analysis for the accumulation of ubiquitinated proteins (as positive control for the proteasomal inhibitors) and AGAP2 levels in CML cell lines treated with proteasomal inhibitors: MG132 [KU812 (5 μM), TCC-S (5 μM), KCL-22 (50 μM) for 4 h] and Bortezomib [KU812 (200 nM), TCC-S (10 nM), KCL-22 (100 nM) for 6 h]. β-Actin levels were used as a loading control. All data shown in the graphs in this figure are the mean ± SD from three independent experiments (performed in triplicate in the case of qPCRs); (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001).

Article Snippet: KU812 (Human chronic myelogenous leukaemia) , ATCC , Cat#CRL-209; RRID:CVCL_0379.

Techniques: Quantitative RT-PCR, Comparison, Western Blot, Control, Expressing, Positive Control

Alternative TSS usage for AGAP2 in PC and CML cell lines leads to differential 5′ UTR isoforms (A) Image derived from the ZENBU browser ( http://fantom.gsc.riken.jp/zenbu/ ) showing the main TSSs in AGAP2 and its frequency (height of peaks). 5′ RACE was performed according to the manufacturer’s instructions using adenines for the tailing reaction. KU812, a CML cell line, presents with an upstream TSS that produces an AGAP2 mRNA with a slightly longer (35 bp) 5′ UTR than the one found in DU145, a PC cell line. In those extra nucleotides, there is a repetition of guanine residues that fits the pattern predicted for the formation of G quadruplexes. (B) Comparison of the frequency of alternative TSSs used in DU145 (PC) and KU812 (CML) cell lines, mapped by 5′ RLM-RACE. The relative frequencies (in percentages) are shown as bars placed at the nucleotide position upstream from the start codon (n = 10). (C) TSSs for AGAP2 in KU812 obtained by 5′ RLM-RACE is plotted against the TSSs noted by the FANTOM CAGE database. (D) Cartoon representing AGAP2 core promoter and its TSSs. The differential TSS selection creates slight differences in the length of the 5′ UTR, with upstream/earlier TSSs resulting in longer 5′ UTRs. The selection of an earlier TSS in CML KU812 produces an mRNA that encodes extra nucleotides in the 5′ UTR containing the consensus for a G quadruplex structure. (E) Relative levels of the longer AGAP2 5′ UTR containing the G quadruplex consensus sequence in PC and CML cell lines. The data represent the mean ± SD of three independent experiments. Statistical differences were analyzed by one-way ANOVA[F (5, 12) = 29.35, p < 0.0001)] with post-hoc Sidak’s multiple comparison tests, p-values shown. (∗p < 0.05; ∗∗∗p < 0.001).

Journal: iScience

Article Title: Implications of differential transcription start site selection on chronic myeloid leukemia and prostate cancer cell protein expression

doi: 10.1016/j.isci.2022.105519

Figure Lengend Snippet: Alternative TSS usage for AGAP2 in PC and CML cell lines leads to differential 5′ UTR isoforms (A) Image derived from the ZENBU browser ( http://fantom.gsc.riken.jp/zenbu/ ) showing the main TSSs in AGAP2 and its frequency (height of peaks). 5′ RACE was performed according to the manufacturer’s instructions using adenines for the tailing reaction. KU812, a CML cell line, presents with an upstream TSS that produces an AGAP2 mRNA with a slightly longer (35 bp) 5′ UTR than the one found in DU145, a PC cell line. In those extra nucleotides, there is a repetition of guanine residues that fits the pattern predicted for the formation of G quadruplexes. (B) Comparison of the frequency of alternative TSSs used in DU145 (PC) and KU812 (CML) cell lines, mapped by 5′ RLM-RACE. The relative frequencies (in percentages) are shown as bars placed at the nucleotide position upstream from the start codon (n = 10). (C) TSSs for AGAP2 in KU812 obtained by 5′ RLM-RACE is plotted against the TSSs noted by the FANTOM CAGE database. (D) Cartoon representing AGAP2 core promoter and its TSSs. The differential TSS selection creates slight differences in the length of the 5′ UTR, with upstream/earlier TSSs resulting in longer 5′ UTRs. The selection of an earlier TSS in CML KU812 produces an mRNA that encodes extra nucleotides in the 5′ UTR containing the consensus for a G quadruplex structure. (E) Relative levels of the longer AGAP2 5′ UTR containing the G quadruplex consensus sequence in PC and CML cell lines. The data represent the mean ± SD of three independent experiments. Statistical differences were analyzed by one-way ANOVA[F (5, 12) = 29.35, p < 0.0001)] with post-hoc Sidak’s multiple comparison tests, p-values shown. (∗p < 0.05; ∗∗∗p < 0.001).

Article Snippet: KU812 (Human chronic myelogenous leukaemia) , ATCC , Cat#CRL-209; RRID:CVCL_0379.

Techniques: Derivative Assay, Comparison, Selection, Sequencing

The G quadruplex (G4) structure in AGAP2 longer 5′ UTR influences mRNA translation negatively (A) Schematic representation of the fragments cloned into the bicistronic luciferase reporter (pcDNA3 RLUC POLIRES FLUC) plasmid. The AGAP2 5′ UTR fragments (shorter 5′ UTR, longer 5′ UTR with G4 consensus, and longer 5′ UTR with G4 consensus mutated) were inserted at the unique Nhe I restriction site proximal to the Renilla luciferase (Rluc) ORF. The Rluc is driven by cap-dependent mRNA translation through the cloned 5′ UTR. The Firefly luciferase cistron was used as an internal control for normalization. (B) Relative luciferase activity of the AGAP2 5′ UTR constructs measured using an in vitro transcription and translation system. The graph represents the mean of 4 independent experiments +/- standard deviation and data are expressed as the Rluc/Fluc ratio relative to the activity of the shorter 5′ UTR. Differences were analyzed using a Kruskal-Wallis [H (2) = 47.13, p =<0.001] followed by Mann-Whitney U test (∗∗∗p < 0.001). (C) Relative luciferase activity after transfecting the different constructs in DU145 and KU812 cells. The luciferase activity was analyzed 48 h after transfection in DU145 and 6 h after transfection in KU812. The graph represents the mean of three independent experiments performed in duplicate and expressed as relative Rluc/Fluc ratios. Differences between samples were analyzed with a Kruskal Wallis test followed by the Mann-Whitney U test, ∗∗∗p < 0.001. The bars represent the mean ± standard deviation. (D) Lysates for polysome profiling were prepared from KU812 and TCC-S cells and fractionated through a sucrose gradient. The profiles were monitored by measuring the absorbance at 254 nm (A 254 nm ). A representative polysome profile from a KU812 extraction is shown on the left. The relative distribution of the mRNA for AGAP2 longer 5′ UTR isoform (concentrated in the non-polysomal fractions) is shown on the right. The abundance of the RNA detected per fraction is presented as the percentage of the total RNA. mRNA levels were normalized to exogenous spike-in luciferase control mRNA. The graph represents the mean ± SEM of two independent experiments.

Journal: iScience

Article Title: Implications of differential transcription start site selection on chronic myeloid leukemia and prostate cancer cell protein expression

doi: 10.1016/j.isci.2022.105519

Figure Lengend Snippet: The G quadruplex (G4) structure in AGAP2 longer 5′ UTR influences mRNA translation negatively (A) Schematic representation of the fragments cloned into the bicistronic luciferase reporter (pcDNA3 RLUC POLIRES FLUC) plasmid. The AGAP2 5′ UTR fragments (shorter 5′ UTR, longer 5′ UTR with G4 consensus, and longer 5′ UTR with G4 consensus mutated) were inserted at the unique Nhe I restriction site proximal to the Renilla luciferase (Rluc) ORF. The Rluc is driven by cap-dependent mRNA translation through the cloned 5′ UTR. The Firefly luciferase cistron was used as an internal control for normalization. (B) Relative luciferase activity of the AGAP2 5′ UTR constructs measured using an in vitro transcription and translation system. The graph represents the mean of 4 independent experiments +/- standard deviation and data are expressed as the Rluc/Fluc ratio relative to the activity of the shorter 5′ UTR. Differences were analyzed using a Kruskal-Wallis [H (2) = 47.13, p =<0.001] followed by Mann-Whitney U test (∗∗∗p < 0.001). (C) Relative luciferase activity after transfecting the different constructs in DU145 and KU812 cells. The luciferase activity was analyzed 48 h after transfection in DU145 and 6 h after transfection in KU812. The graph represents the mean of three independent experiments performed in duplicate and expressed as relative Rluc/Fluc ratios. Differences between samples were analyzed with a Kruskal Wallis test followed by the Mann-Whitney U test, ∗∗∗p < 0.001. The bars represent the mean ± standard deviation. (D) Lysates for polysome profiling were prepared from KU812 and TCC-S cells and fractionated through a sucrose gradient. The profiles were monitored by measuring the absorbance at 254 nm (A 254 nm ). A representative polysome profile from a KU812 extraction is shown on the left. The relative distribution of the mRNA for AGAP2 longer 5′ UTR isoform (concentrated in the non-polysomal fractions) is shown on the right. The abundance of the RNA detected per fraction is presented as the percentage of the total RNA. mRNA levels were normalized to exogenous spike-in luciferase control mRNA. The graph represents the mean ± SEM of two independent experiments.

Article Snippet: KU812 (Human chronic myelogenous leukaemia) , ATCC , Cat#CRL-209; RRID:CVCL_0379.

Techniques: Clone Assay, Luciferase, Plasmid Preparation, Control, Activity Assay, Construct, In Vitro, Standard Deviation, MANN-WHITNEY, Transfection, Extraction

Identification of potential targets regulated in a similar manner to AGAP2 (A) Workflow diagram used to identify genes whose expression could be regulated by the alternative selection of a TSSs, involving the presence of a G quadruplex (G4). First, the FANTOM database was used to identify all the transcripts that contained a G quadruplex (G4) consensus sequence between alternative TSSs within their defined TSS cluster. The G4 consensus sequences were identified using the pqsfinder package in R. The FANTOM database was also used to detect differential expression in PC (DU145, PC3) and CML (KU812, K562, KCL-22) cell lines for those genes that would encode a G4 consensus between alternative TSSs. Microarray and SWATH-MS data from the NCI-60 database were integrated to characterize genes that demonstrated discrepancies between their mRNA and protein levels (high mRNA and low protein) within those genes showing a differential 5′ UTRs with G4 sequences. (B) Metacore pathway enrichment analysis of mRNAs with alternative 5′ UTRs that contain G4 consensus sequences. The dot plot shows the top 15 enriched pathways with the largest gene ratio. The size of the dots represents the number of genes in each pathway and the color of the dots represents the adjusted p values (BH). (C) Venn diagram illustrating the overlapping genes in the FANTOM and NCI-60 databases showing differential 5′ UTRs with G4 consensus, with differentially expressed mRNA (≥1 log FC), and either no statistically significant differences in protein levels or significantly lower proteins levels in CML cell lines (left) or PC cell lines (right). The differential expression and TSS distribution were computed by linear modeling followed by empirical Bayes statistics.

Journal: iScience

Article Title: Implications of differential transcription start site selection on chronic myeloid leukemia and prostate cancer cell protein expression

doi: 10.1016/j.isci.2022.105519

Figure Lengend Snippet: Identification of potential targets regulated in a similar manner to AGAP2 (A) Workflow diagram used to identify genes whose expression could be regulated by the alternative selection of a TSSs, involving the presence of a G quadruplex (G4). First, the FANTOM database was used to identify all the transcripts that contained a G quadruplex (G4) consensus sequence between alternative TSSs within their defined TSS cluster. The G4 consensus sequences were identified using the pqsfinder package in R. The FANTOM database was also used to detect differential expression in PC (DU145, PC3) and CML (KU812, K562, KCL-22) cell lines for those genes that would encode a G4 consensus between alternative TSSs. Microarray and SWATH-MS data from the NCI-60 database were integrated to characterize genes that demonstrated discrepancies between their mRNA and protein levels (high mRNA and low protein) within those genes showing a differential 5′ UTRs with G4 sequences. (B) Metacore pathway enrichment analysis of mRNAs with alternative 5′ UTRs that contain G4 consensus sequences. The dot plot shows the top 15 enriched pathways with the largest gene ratio. The size of the dots represents the number of genes in each pathway and the color of the dots represents the adjusted p values (BH). (C) Venn diagram illustrating the overlapping genes in the FANTOM and NCI-60 databases showing differential 5′ UTRs with G4 consensus, with differentially expressed mRNA (≥1 log FC), and either no statistically significant differences in protein levels or significantly lower proteins levels in CML cell lines (left) or PC cell lines (right). The differential expression and TSS distribution were computed by linear modeling followed by empirical Bayes statistics.

Article Snippet: KU812 (Human chronic myelogenous leukaemia) , ATCC , Cat#CRL-209; RRID:CVCL_0379.

Techniques: Expressing, Selection, Sequencing, Quantitative Proteomics, Microarray, Data-independent acquisition

HK1 expression is also regulated by an alternative TSSs and mediation of a G4 structure (A) HK1 mRNA basal levels were detected in prostate cancer (PC) cell lines (DU145, PC3, and LNCaP) and chronic myeloid leukemia (CML) cell lines (KU812, TCC-S, and KCL-22) by RT-qPCR. HK1 expression was normalized against levels for the housekeeping gene HPRT and it is shown relative to levels in the PC cell line DU145. The difference in RNA expression was analyzed using one-way ANOVA[F (5, 12) = 22.25, p < 0.001)] with post-hoc Sidak’s multiple comparison tests, P-values shown (∗∗∗p < 0.001). The error bars denote standard deviation. (B) HK I protein levels were detected by western blot. The graph later in discussion shows overall densitometry values relative to those in the DU145 cell line. (C) Relative expression levels for the HK1 isoform with the longer 5′ UTR containing a G4 consensus sequence, detected by RT-qPCR in PC and CML cell lines. The bars represent the mean ± SD of three independent experiments. Statistical differences were analyzed by one-way ANOVA[F (5, 12) = 8.6, p < 0.001)] with post-hoc Sidak’s multiple comparison tests, p-values shown (∗p < 0.05; ∗∗p < 0.01). (D) rG4IP followed by HK1 detection by RT-qPCR. Expression levels were normalized by input control, and the data presented correspond to three independent immunoprecipitations. The error bars denote the standard deviation. Differences between samples were analyzed by unpaired two-tailed t-tests, P-values shown. (E) Polysomal fractionation: relative abundance of the HK1 mRNA with the longer 5′ UTR in polysome fractions in TCC-S cells (left) and KU812 cells (right).

Journal: iScience

Article Title: Implications of differential transcription start site selection on chronic myeloid leukemia and prostate cancer cell protein expression

doi: 10.1016/j.isci.2022.105519

Figure Lengend Snippet: HK1 expression is also regulated by an alternative TSSs and mediation of a G4 structure (A) HK1 mRNA basal levels were detected in prostate cancer (PC) cell lines (DU145, PC3, and LNCaP) and chronic myeloid leukemia (CML) cell lines (KU812, TCC-S, and KCL-22) by RT-qPCR. HK1 expression was normalized against levels for the housekeeping gene HPRT and it is shown relative to levels in the PC cell line DU145. The difference in RNA expression was analyzed using one-way ANOVA[F (5, 12) = 22.25, p < 0.001)] with post-hoc Sidak’s multiple comparison tests, P-values shown (∗∗∗p < 0.001). The error bars denote standard deviation. (B) HK I protein levels were detected by western blot. The graph later in discussion shows overall densitometry values relative to those in the DU145 cell line. (C) Relative expression levels for the HK1 isoform with the longer 5′ UTR containing a G4 consensus sequence, detected by RT-qPCR in PC and CML cell lines. The bars represent the mean ± SD of three independent experiments. Statistical differences were analyzed by one-way ANOVA[F (5, 12) = 8.6, p < 0.001)] with post-hoc Sidak’s multiple comparison tests, p-values shown (∗p < 0.05; ∗∗p < 0.01). (D) rG4IP followed by HK1 detection by RT-qPCR. Expression levels were normalized by input control, and the data presented correspond to three independent immunoprecipitations. The error bars denote the standard deviation. Differences between samples were analyzed by unpaired two-tailed t-tests, P-values shown. (E) Polysomal fractionation: relative abundance of the HK1 mRNA with the longer 5′ UTR in polysome fractions in TCC-S cells (left) and KU812 cells (right).

Article Snippet: KU812 (Human chronic myelogenous leukaemia) , ATCC , Cat#CRL-209; RRID:CVCL_0379.

Techniques: Expressing, Quantitative RT-PCR, RNA Expression, Comparison, Standard Deviation, Western Blot, Sequencing, Control, Two Tailed Test, Fractionation

Journal: iScience

Article Title: Implications of differential transcription start site selection on chronic myeloid leukemia and prostate cancer cell protein expression

doi: 10.1016/j.isci.2022.105519

Figure Lengend Snippet:

Article Snippet: KU812 (Human chronic myelogenous leukaemia) , ATCC , Cat#CRL-209; RRID:CVCL_0379.

Techniques: Control, Virus, Recombinant, Protease Inhibitor, Reporter Assay, Plasmid Preparation, TA Cloning, Bicinchoninic Acid Protein Assay, Reverse Transcription, Western Blot, Transfection, Microarray, Data-independent acquisition, Circular Dichroism, Mutagenesis, Software, Sequencing, Membrane, Cell Culture, Modification

 CircRNA_103827  and circRNA_104816 expressions in granulosa cells according to patients’ clinical characteristics.

Journal: PLoS ONE

Article Title: Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes

doi: 10.1371/journal.pone.0177888

Figure Lengend Snippet: CircRNA_103827 and circRNA_104816 expressions in granulosa cells according to patients’ clinical characteristics.

Article Snippet: In stage 1, GCs samples from women of advanced age (AA, ≥ 38 years, n = 3) and young age (YA, ≤ 30 years, n = 3) were analyzed by a human circRNA microarray (8×15K, Arraystar Inc.).

Techniques: Biomarker Discovery

 CircRNA_103827  and circRNA_104816 expression levels in granulosa cells according to ART outcomes.

Journal: PLoS ONE

Article Title: Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes

doi: 10.1371/journal.pone.0177888

Figure Lengend Snippet: CircRNA_103827 and circRNA_104816 expression levels in granulosa cells according to ART outcomes.

Article Snippet: In stage 1, GCs samples from women of advanced age (AA, ≥ 38 years, n = 3) and young age (YA, ≤ 30 years, n = 3) were analyzed by a human circRNA microarray (8×15K, Arraystar Inc.).

Techniques: Expressing

The top 10 significantly differentially expressed circRNAs between young and older women ranked by fold change.

Journal: PLoS ONE

Article Title: Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes

doi: 10.1371/journal.pone.0177888

Figure Lengend Snippet: The top 10 significantly differentially expressed circRNAs between young and older women ranked by fold change.

Article Snippet: In stage 1, GCs samples from women of advanced age (AA, ≥ 38 years, n = 3) and young age (YA, ≤ 30 years, n = 3) were analyzed by a human circRNA microarray (8×15K, Arraystar Inc.).

Techniques:

Comparison of candidate circRNAs (circRNA_103829, circRNA_10827, circRNA_104816, circRNA_101889, circRNA_103828, circRNA_100833, circRNA_104852, circRNA_103611) expression levels in granulosa cells from additional young (n = 20) and older (n = 20) women by qRT-PCR. YA, women with young age (≤ 30 years); AA, women with advanced age (≥ 38 years). P values were calculated by Mann-Whitney U test. Relative expressions were analyzed by 2 -ΔΔCt method which was normalized to GAPDH. For each box plotting, the central mark represents the median, the edges of the box represent the 25 th and 75 th percentiles, and the whiskers are the most extreme data points not considered outliers.

Journal: PLoS ONE

Article Title: Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes

doi: 10.1371/journal.pone.0177888

Figure Lengend Snippet: Comparison of candidate circRNAs (circRNA_103829, circRNA_10827, circRNA_104816, circRNA_101889, circRNA_103828, circRNA_100833, circRNA_104852, circRNA_103611) expression levels in granulosa cells from additional young (n = 20) and older (n = 20) women by qRT-PCR. YA, women with young age (≤ 30 years); AA, women with advanced age (≥ 38 years). P values were calculated by Mann-Whitney U test. Relative expressions were analyzed by 2 -ΔΔCt method which was normalized to GAPDH. For each box plotting, the central mark represents the median, the edges of the box represent the 25 th and 75 th percentiles, and the whiskers are the most extreme data points not considered outliers.

Article Snippet: In stage 1, GCs samples from women of advanced age (AA, ≥ 38 years, n = 3) and young age (YA, ≤ 30 years, n = 3) were analyzed by a human circRNA microarray (8×15K, Arraystar Inc.).

Techniques: Comparison, Expressing, Quantitative RT-PCR, MANN-WHITNEY

( A-E ) circRNA_103827 expression levels in granulosa cells according to (A) serum AMH levels, (B) AFC, (C) retrieved oocytes, (D) top quality embryos and (E) top quality embryo percentage. ( F-J ) circRNA_104816 expression levels in granulosa cells according to (F) serum AMH levels, (G) AFC, (H) retrieved oocytes, (I) top quality embryos and (J) top quality embryo percentage.

Journal: PLoS ONE

Article Title: Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes

doi: 10.1371/journal.pone.0177888

Figure Lengend Snippet: ( A-E ) circRNA_103827 expression levels in granulosa cells according to (A) serum AMH levels, (B) AFC, (C) retrieved oocytes, (D) top quality embryos and (E) top quality embryo percentage. ( F-J ) circRNA_104816 expression levels in granulosa cells according to (F) serum AMH levels, (G) AFC, (H) retrieved oocytes, (I) top quality embryos and (J) top quality embryo percentage.

Article Snippet: In stage 1, GCs samples from women of advanced age (AA, ≥ 38 years, n = 3) and young age (YA, ≤ 30 years, n = 3) were analyzed by a human circRNA microarray (8×15K, Arraystar Inc.).

Techniques: Expressing

ROC analysis to evaluate predictive performance of circRNA_103827, circRNA_104816 expressions in granulosa cells and top quality embryo proportion for ( A-C ) clinical pregnancy outcomes, as well as for ( D-F ) live births. AUC, area under the ROC curve.

Journal: PLoS ONE

Article Title: Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes

doi: 10.1371/journal.pone.0177888

Figure Lengend Snippet: ROC analysis to evaluate predictive performance of circRNA_103827, circRNA_104816 expressions in granulosa cells and top quality embryo proportion for ( A-C ) clinical pregnancy outcomes, as well as for ( D-F ) live births. AUC, area under the ROC curve.

Article Snippet: In stage 1, GCs samples from women of advanced age (AA, ≥ 38 years, n = 3) and young age (YA, ≤ 30 years, n = 3) were analyzed by a human circRNA microarray (8×15K, Arraystar Inc.).

Techniques:

(A) CircRNA_103827/circRNA_104816 targeted “Top 5” miRNA-gene network was portrayed based on sequence-pairing prediction. A pink round node represents a gene, a blue square represents miRNA, and a yellow diamond represents a circRNA. Overlapping genes of both circRNAs in this interactive network were ANKRD20A9P , XIST and KCNQ1OT1 . (B) GO and (C) KEGG pathway analysis of circRNA_103827 and circRNA_104816 predicted target genes. The top 10 significantly enriched activities and their scores (negative logarithm of P value) were listed in the X-axis and the Y-axis, respectively.

Journal: PLoS ONE

Article Title: Circular RNA expression profiling of human granulosa cells during maternal aging reveals novel transcripts associated with assisted reproductive technology outcomes

doi: 10.1371/journal.pone.0177888

Figure Lengend Snippet: (A) CircRNA_103827/circRNA_104816 targeted “Top 5” miRNA-gene network was portrayed based on sequence-pairing prediction. A pink round node represents a gene, a blue square represents miRNA, and a yellow diamond represents a circRNA. Overlapping genes of both circRNAs in this interactive network were ANKRD20A9P , XIST and KCNQ1OT1 . (B) GO and (C) KEGG pathway analysis of circRNA_103827 and circRNA_104816 predicted target genes. The top 10 significantly enriched activities and their scores (negative logarithm of P value) were listed in the X-axis and the Y-axis, respectively.

Article Snippet: In stage 1, GCs samples from women of advanced age (AA, ≥ 38 years, n = 3) and young age (YA, ≤ 30 years, n = 3) were analyzed by a human circRNA microarray (8×15K, Arraystar Inc.).

Techniques: Sequencing

circRNAs expression profiles detected by microarray in the AAA group and control group. a The box plot shows the nearly identical distributions of normalized intensity values from the aortic samples of the AAA and control group. b The scatter plot is built to assess the expression variation of circRNAs between the two groups. The X and Y axes indicate the normalized intensity values of each circRNAs from the AAA and control group. The dots above the upper green line and below the lower green line represent the dysregulated circRNAs with a fold change (FC) > 2.0 between the two groups. c The volcano plot presents differentially expressed circRNAs in AAA. The vertical lines correspond to 2-fold upregulation and downregulation, the horizontal line indicates P value of 0.05. The red dots represent the differentially expressed circRNAs (FC > 2.0 and P value < 0.05). d Hierarchical clustering analysis reveals a distinguishable expression profile of circRNAs between the AAA and control group. Each column indicates an aortic sample, each row represents a circRNA. The red and green color indicate high and low expression level, respectively. e Chromosomal distribution of the differentially expressed circRNAs between the two groups

Journal: BMC Cardiovascular Disorders

Article Title: Circular RNA expression profile and its potential regulative role in human abdominal aortic aneurysm

doi: 10.1186/s12872-020-01374-8

Figure Lengend Snippet: circRNAs expression profiles detected by microarray in the AAA group and control group. a The box plot shows the nearly identical distributions of normalized intensity values from the aortic samples of the AAA and control group. b The scatter plot is built to assess the expression variation of circRNAs between the two groups. The X and Y axes indicate the normalized intensity values of each circRNAs from the AAA and control group. The dots above the upper green line and below the lower green line represent the dysregulated circRNAs with a fold change (FC) > 2.0 between the two groups. c The volcano plot presents differentially expressed circRNAs in AAA. The vertical lines correspond to 2-fold upregulation and downregulation, the horizontal line indicates P value of 0.05. The red dots represent the differentially expressed circRNAs (FC > 2.0 and P value < 0.05). d Hierarchical clustering analysis reveals a distinguishable expression profile of circRNAs between the AAA and control group. Each column indicates an aortic sample, each row represents a circRNA. The red and green color indicate high and low expression level, respectively. e Chromosomal distribution of the differentially expressed circRNAs between the two groups

Article Snippet: The fragmented labeled cRNAs were hybridized onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2).

Techniques: Expressing, Microarray, Control

Validation of six randomly selected dysregulated circRNAs by qRT-PCR. Each circRNA was evaluated at least three times and compared with the results of microarray. The Y axis indicates the fold change of AAA vs control of each circRNA

Journal: BMC Cardiovascular Disorders

Article Title: Circular RNA expression profile and its potential regulative role in human abdominal aortic aneurysm

doi: 10.1186/s12872-020-01374-8

Figure Lengend Snippet: Validation of six randomly selected dysregulated circRNAs by qRT-PCR. Each circRNA was evaluated at least three times and compared with the results of microarray. The Y axis indicates the fold change of AAA vs control of each circRNA

Article Snippet: The fragmented labeled cRNAs were hybridized onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2).

Techniques: Biomarker Discovery, Quantitative RT-PCR, Microarray, Control

The predicted circRNA/miRNA interaction networks for six randomly selected circRNAs. a , b The red nodes indicate upregulated circRNAs. c - f The blue nodes represent downregulated circRNAs. The green nodes are five complementary binding miRNAs of each circRNA

Journal: BMC Cardiovascular Disorders

Article Title: Circular RNA expression profile and its potential regulative role in human abdominal aortic aneurysm

doi: 10.1186/s12872-020-01374-8

Figure Lengend Snippet: The predicted circRNA/miRNA interaction networks for six randomly selected circRNAs. a , b The red nodes indicate upregulated circRNAs. c - f The blue nodes represent downregulated circRNAs. The green nodes are five complementary binding miRNAs of each circRNA

Article Snippet: The fragmented labeled cRNAs were hybridized onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2).

Techniques: Binding Assay

Comparison of circRNA expression profiles between HPA-v and adipocytes. (A) Box plots revealed the distribution of circRNAs in the six samples after normalization. (B) Volcano plots revealed the differentially expressed circRNAs. Green and red dots represent significantly down- and upregulated circRNAs in adipocytes compared with HPA-v, respectively (fold change ≥5.0, P<0.01). (C) Hierarchical clustering was performed to reveal the differentially expressed circRNAs between HPA-v and adipocytes. (D) Expression patterns of select differentially expressed circRNAs in HPA-v and adipocytes were determined by qPCR. (E) The heatmap revealed the selected differentially expressed circRNAs in HPA-v and adipocytes. *P<0.05. circRNA, circular RNA; HPA-v, human preadipocytes from visceral fat tissue; AD, adipocytes; n.d., not detected.

Journal: Molecular Medicine Reports

Article Title: CircRNA expression profiles in human visceral preadipocytes and adipocytes

doi: 10.3892/mmr.2019.10886

Figure Lengend Snippet: Comparison of circRNA expression profiles between HPA-v and adipocytes. (A) Box plots revealed the distribution of circRNAs in the six samples after normalization. (B) Volcano plots revealed the differentially expressed circRNAs. Green and red dots represent significantly down- and upregulated circRNAs in adipocytes compared with HPA-v, respectively (fold change ≥5.0, P<0.01). (C) Hierarchical clustering was performed to reveal the differentially expressed circRNAs between HPA-v and adipocytes. (D) Expression patterns of select differentially expressed circRNAs in HPA-v and adipocytes were determined by qPCR. (E) The heatmap revealed the selected differentially expressed circRNAs in HPA-v and adipocytes. *P<0.05. circRNA, circular RNA; HPA-v, human preadipocytes from visceral fat tissue; AD, adipocytes; n.d., not detected.

Article Snippet: To investigate whether circRNAs are associated with lipid deposition, a human circRNA microarray (version 2.0; Agilent Technologies, Inc.) was used to assess circRNA expression profiles in HPA-v and adipocytes.

Techniques: Expressing

Top 10 up- and downregulated circRNAs in adipocytes.

Journal: Molecular Medicine Reports

Article Title: CircRNA expression profiles in human visceral preadipocytes and adipocytes

doi: 10.3892/mmr.2019.10886

Figure Lengend Snippet: Top 10 up- and downregulated circRNAs in adipocytes.

Article Snippet: To investigate whether circRNAs are associated with lipid deposition, a human circRNA microarray (version 2.0; Agilent Technologies, Inc.) was used to assess circRNA expression profiles in HPA-v and adipocytes.

Techniques:

The top 15 significantly enriched pathways associated with the differentially expressed circRNA parental genes according to KEGG analysis. circRNAs, circular RNAs; KEGG, Kyoto Encyclopedia of Genes and Genomes.

Journal: Molecular Medicine Reports

Article Title: CircRNA expression profiles in human visceral preadipocytes and adipocytes

doi: 10.3892/mmr.2019.10886

Figure Lengend Snippet: The top 15 significantly enriched pathways associated with the differentially expressed circRNA parental genes according to KEGG analysis. circRNAs, circular RNAs; KEGG, Kyoto Encyclopedia of Genes and Genomes.

Article Snippet: To investigate whether circRNAs are associated with lipid deposition, a human circRNA microarray (version 2.0; Agilent Technologies, Inc.) was used to assess circRNA expression profiles in HPA-v and adipocytes.

Techniques:

miRNAs with >2 miRNA response elements targeting the top 10 upregulated and downregulated circRNAs.

Journal: Molecular Medicine Reports

Article Title: CircRNA expression profiles in human visceral preadipocytes and adipocytes

doi: 10.3892/mmr.2019.10886

Figure Lengend Snippet: miRNAs with >2 miRNA response elements targeting the top 10 upregulated and downregulated circRNAs.

Article Snippet: To investigate whether circRNAs are associated with lipid deposition, a human circRNA microarray (version 2.0; Agilent Technologies, Inc.) was used to assess circRNA expression profiles in HPA-v and adipocytes.

Techniques:

IDD datasets included for analysis

Journal: Journal of Orthopaedic Surgery and Research

Article Title: Comprehensive analysis of potential ceRNA network and immune cell infiltration in intervertebral disc degeneration

doi: 10.1186/s13018-022-03331-x

Figure Lengend Snippet: IDD datasets included for analysis

Article Snippet: GSE67566 , GPL19978 Agilent-069978 Arraystar Human CircRNA microarray V1 , 5 , 5.

Techniques: Microarray

Schematic illustration of the effect of circular RNAs (circRNAs) on intracranial aneurysm (IA) rupture. Current evidence strongly suggests a central role for endothelial dysfunction in the initiation and progression of IA. Post-subarachnoid hemorrhage (SAH), several early pathophysiological events can be commonly observed in blood-brain barrier (BBB) components, such as the endothelium (endothelial dysfunction). In results, post- SAH injuries can disrupt the integrity and function of the BBB . Both negative (red cross) and positive (green cross) regulation of circRNAs have been observed in this pathological cascade. The role of circRNAs is based on components: 1) strong role in endothelial cells (ECs) homeostasis; 2) regulation of barrier function and vascular tone; 3) associated with SAH and its complications; 4) correlates with clinical outcomes (Glasgow Coma Scale, the volume of SAH, modified Fisher scale, Hunt-Hess levels, and surgical type; 5) regulators of transcription/translation, sequesters of microRNA (miRNA)/RNA-binding proteins (RBPs), and biomarkers of IA.

Journal: Non-coding RNA Research

Article Title: Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

doi: 10.1016/j.ncrna.2023.11.012

Figure Lengend Snippet: Schematic illustration of the effect of circular RNAs (circRNAs) on intracranial aneurysm (IA) rupture. Current evidence strongly suggests a central role for endothelial dysfunction in the initiation and progression of IA. Post-subarachnoid hemorrhage (SAH), several early pathophysiological events can be commonly observed in blood-brain barrier (BBB) components, such as the endothelium (endothelial dysfunction). In results, post- SAH injuries can disrupt the integrity and function of the BBB . Both negative (red cross) and positive (green cross) regulation of circRNAs have been observed in this pathological cascade. The role of circRNAs is based on components: 1) strong role in endothelial cells (ECs) homeostasis; 2) regulation of barrier function and vascular tone; 3) associated with SAH and its complications; 4) correlates with clinical outcomes (Glasgow Coma Scale, the volume of SAH, modified Fisher scale, Hunt-Hess levels, and surgical type; 5) regulators of transcription/translation, sequesters of microRNA (miRNA)/RNA-binding proteins (RBPs), and biomarkers of IA.

Article Snippet: Leveraging the power of the Arraystar human circRNAs microarray, differentially expressed circRNAs between patients with UIAs and RIAs were meticulously analyzed.

Techniques: Modification, RNA Binding Assay

Schematic illustration of circular RNAs (circRNAs) regulation mechanisms underlying vascular smooth muscle cells (VSMCs) phenotypic modulation, oxidative stress, and cell death in intracranial aneurysms (IAs). As can be seen from the figure, circRNAs play a role both in the development and progression of IA and in the inhibition of IA through the control of VSMC. However, some of them exhibit a double effect as circ_FOXO3 and circ_0020397.

Journal: Non-coding RNA Research

Article Title: Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

doi: 10.1016/j.ncrna.2023.11.012

Figure Lengend Snippet: Schematic illustration of circular RNAs (circRNAs) regulation mechanisms underlying vascular smooth muscle cells (VSMCs) phenotypic modulation, oxidative stress, and cell death in intracranial aneurysms (IAs). As can be seen from the figure, circRNAs play a role both in the development and progression of IA and in the inhibition of IA through the control of VSMC. However, some of them exhibit a double effect as circ_FOXO3 and circ_0020397.

Article Snippet: Leveraging the power of the Arraystar human circRNAs microarray, differentially expressed circRNAs between patients with UIAs and RIAs were meticulously analyzed.

Techniques: Inhibition

Benefits of using cell free circular RNAs (circRNAs) as biomarkers.

Journal: Non-coding RNA Research

Article Title: Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

doi: 10.1016/j.ncrna.2023.11.012

Figure Lengend Snippet: Benefits of using cell free circular RNAs (circRNAs) as biomarkers.

Article Snippet: Leveraging the power of the Arraystar human circRNAs microarray, differentially expressed circRNAs between patients with UIAs and RIAs were meticulously analyzed.

Techniques:

The studied cell free circular RNAs (circRNAs) are presented as non-invasive biomarkers in intracranial aneurysms (IAs).

Journal: Non-coding RNA Research

Article Title: Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

doi: 10.1016/j.ncrna.2023.11.012

Figure Lengend Snippet: The studied cell free circular RNAs (circRNAs) are presented as non-invasive biomarkers in intracranial aneurysms (IAs).

Article Snippet: Leveraging the power of the Arraystar human circRNAs microarray, differentially expressed circRNAs between patients with UIAs and RIAs were meticulously analyzed.

Techniques:

Summary information on the role of circular RNAs  (circRNAs)  in the formation and development of intracranial aneurysms (IAs).

Journal: Non-coding RNA Research

Article Title: Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

doi: 10.1016/j.ncrna.2023.11.012

Figure Lengend Snippet: Summary information on the role of circular RNAs (circRNAs) in the formation and development of intracranial aneurysms (IAs).

Article Snippet: Leveraging the power of the Arraystar human circRNAs microarray, differentially expressed circRNAs between patients with UIAs and RIAs were meticulously analyzed.

Techniques: Migration, Transformation Assay